The historical rank and industry rank for Isleworth Healthcare Acquisition's Return-on-Tangible-Equity or its related term are showing as below:
ISLEW'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 4.86 Med: 4.86 Max: 5.22
Current: 5.22
During the past 2 years, Isleworth Healthcare Acquisition's highest Return-on-Tangible-Equity was 5.22%. The lowest was 4.86%. And the median was 4.86%.
ISLEW's Return-on-Tangible-Equity is not ranked
in the Diversified Financial Services industry.
Industry Median: 1.65
vs ISLEW: 5.22
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Isleworth Healthcare Acquisition Return-on-Tangible-Equity Related Terms
Isleworth Healthcare Acquisition Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISLEW vs AVAC, TRCA, IFIN: Return-on-Tangible-Equity Comparison
For the Shell Companies subindustry, Isleworth Healthcare Acquisition's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Isleworth Healthcare Acquisition Return-on-Tangible-Equity vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Isleworth Healthcare Acquisition's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Isleworth Healthcare Acquisition's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2022) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.14% mean?
Isleworth Healthcare Acquisition (ISLEW) has a Return-on-Tangible-Equity of 4.14% as of Jun. 2022. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Isleworth Healthcare Acquisition and its competitors. This is 15% below median its historical median of 4.86. Over the past decade, Isleworth Healthcare Acquisition's Return-on-Tangible-Equity has ranged from 4.86 to 5.22.
Is Isleworth Healthcare Acquisition's Return-on-Tangible-Equity too high?
Isleworth Healthcare Acquisition's current Return-on-Tangible-Equity of 4.14% is 15% below median its 10-year median of 4.86. Over the past 10 years, this metric has ranged from a low of 4.86 to a high of 5.22. The Diversified Financial Services industry median Return-on-Tangible-Equity is 1.65. Isleworth Healthcare Acquisition's value of 4.14% is 150.9% above this industry median.
How does Isleworth Healthcare Acquisition's Return-on-Tangible-Equity compare to AVAC and TRCA?
Isleworth Healthcare Acquisition's Return-on-Tangible-Equity of 4.14% can be compared against companies in the Diversified Financial Services industry. The industry median Return-on-Tangible-Equity is 1.65. Isleworth Healthcare Acquisition's value of 4.14% is 150.9% above this benchmark. Historically, Isleworth Healthcare Acquisition's own Return-on-Tangible-Equity has ranged from 4.86 to 5.22 over the past decade. While the company's 10-year median is 4.86 vs. the industry median of 1.65, Isleworth Healthcare Acquisition has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Diversified Financial Services company?
The median Return-on-Tangible-Equity among Diversified Financial Services companies is 1.65, based on 488 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Isleworth Healthcare Acquisition's current Return-on-Tangible-Equity of 4.14% is 150.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Isleworth Healthcare Acquisition and its competitors. For the Diversified Financial Services industry, the median Return-on-Tangible-Equity is 1.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Isleworth Healthcare Acquisition's current Return-on-Tangible-Equity is 4.14%, which is 15% below median its own 10-year median of 4.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Isleworth Healthcare Acquisition stock overvalued right now?
Isleworth Healthcare Acquisition (ISLEW) has a current Return-on-Tangible-Equity of 4.14%. The current Return-on-Tangible-Equity is 4.14%, which is 15% below median its 10-year median of 4.86 and 150.9% above the Diversified Financial Services industry median of 1.65. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Isleworth Healthcare Acquisition (ISLEW), the current Return-on-Tangible-Equity is 4.14% as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Isleworth Healthcare Acquisition Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISLEW has been successfully added to your